ICON has launched an early phase imaging solution to support faster decision making in research applications.
The new solution incorporates streamlined processes and procedures to maximise the information collected from image data.
The hope is that this will ensure information is processed rapidly in line with the shorter timelines and requirements of early-phase research.
Enhanced decision making is then enabled by MIRA, ICON’s image management system, which standardises data from all imaging formats and allows for centralised analysis and interpretation of data.
Driving this innovation is a team of scientific and regulatory experts with deep imaging and early-phase experience to help sponsors make critical decisions about their compounds faster.
“PET, volumetrics, advanced CT and MRI are increasingly being used in early phase research which has created a demand for more tailored imaging solutions for early phase trials,” commented Ted Gastineau, President, ICON Medical Imaging.
